Inocras

United States
Wonewoc, Wisconsin, United States, 92121

Company profile

Inocras company profile

Inocras provides AI-driven genomic analysis focused on cancer and rare diseases. The company offers whole genome sequencing products, including CancerVision, RareVision, and MRDVision, alongside research services for pharmaceutical and biotechnology organizations through its CAP/CLIA-certified laboratory. Inocras employs a proprietary bioinformatics pipeline to process genomic data, supporting insights for both clinical and research applications. The company integrates sequencing and computational analysis to enable precision health approaches based on individual genomic information.

Business identity

Contact email
[email protected]
Phone number
+1 858 665 2120
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2020-01-09

Headquarters

Postal code
92121
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
6
Total equity funding
$52.4M
Last funding
Series Unknown / 2024-12-05
Last equity funding
Series Unknown
Investors
14
Lead investors
2
Founders
2
Articles
46

Founders and investors

Founders

Jeong Seok LeeYoungseok Ju

Lead investors

Dunamu & PartnersMinistry of SMEs and Startups

Investors

DSC InvestmentInterVest Co.Ministry of SMEs and StartupsSamsung Venture InvestmentSchmidt